Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
Moderna Inc (NASDAQ:MRNA) shares are trading higher Wednesday after the company announced an ongoing collaboration with OpenAI.
What To Know: Moderna said the company and Microsoft Corp (NASDAQ:MSFT)-backed OpenAI share a vision of AI's transformative potential in the future of business and healthcare.
Moderna began a collaboration with OpenAI in early 2023 with the launch of Moderna's own instance of ChatGPT, called mChat. The company announced Wednesday that it has reached more than 80% internal adoption of mChat, which has accelerated the AI culture at Moderna.
As a result of the company's AI integration, Moderna has deployed ChatGPT Enterprise and its enhanced capabilities such as Advanced Analytics, Image Generation and GPTs, which are now embedded across Moderna's business functions as purpose-built assistants working alongside Moderna employees.
"Just as the introduction of the personal computer in the 1980's changed the way we work and live, AI is on a path to completely transform our everyday lives – and OpenAI is helping to lead the way. Both our companies have shared values and are research-driven organizations pushing the boundaries of technology to drive transformation," said Stéphane Bancel, CEO of Moderna.
"Moderna has an ambitious plan to launch multiple products over the next few years, and collaborations with companies like OpenAI are critical to our ability to scale and maximize our impact on patients."
Since adopting ChatGPT in recent months, Moderna said it has deployed more than 750 GPTs that have helped drive automation and productivity.
Moderna is set to report financial results for the first quarter on May 2. The company is expected to report a loss of $3.68 per share and revenue of $97.501 million, according to estimates from Benzinga Pro.
MRNA Price Action: Moderna shares were up 3.9% at $112.10 at the time of publication, according to Benzinga Pro.
Moderna公司(NASDAQ:MRNA) 週三股價走高,此前該公司宣佈與OpenAI持續合作。
須知:Moderna表示,該公司和微軟公司(NASDAQ:MSFT)支持的OpenAI對人工智能在未來商業和醫療保健領域的變革潛力有着共同的願景。
Moderna 於 2023 年初開始與 OpenAI 合作,推出了 Moderna 自己的名爲 mChat 的 ChatGPT 實例。該公司週三宣佈,其內部對mChat的採用率已達到80%以上,這加速了Moderna的人工智能文化。
由於公司的人工智能集成,Moderna已經部署了ChatGPT企業版及其增強功能,例如高級分析、圖像生成和GPT,這些功能現已作爲專門的助手嵌入到Moderna的業務職能中,與Moderna員工一起工作。
“正如20世紀80年代個人計算機的推出改變了我們的工作和生活方式一樣,人工智能正在徹底改變我們的日常生活——而OpenAI正在幫助引領潮流。我們兩家公司都有共同的價值觀,都是以研究爲導向的組織,突破技術界限以推動轉型。” Moderna首席執行官Stephane Bancel說。
“Moderna有一個雄心勃勃的計劃,即在未來幾年內推出多種產品,與OpenAI等公司的合作對於我們擴大和最大限度地擴大對患者的影響至關重要。”
自從最近幾個月採用ChatGPT以來,Moderna表示已經部署了750多個GPT,這些GPT有助於提高自動化和生產力。
Moderna定於5月2日公佈第一季度的財務業績。根據Benzinga Pro的估計,該公司預計將報告每股虧損3.68美元,收入爲9,7501萬美元。
MRNA價格走勢:根據Benzinga Pro的數據,在發佈時,Moderna股價上漲3.9%,至112.10美元。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧